Tissue-specific contribution of Selenoprotein P in colitis and oxidative damage
硒蛋白 P 在结肠炎和氧化损伤中的组织特异性作用
基本信息
- 批准号:9269673
- 负责人:
- 金额:$ 5.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-07 至 2019-05-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAntioxidantsAreaAzoxymethaneBone MarrowBuffersCarcinomaCell physiologyCellsCoculture TechniquesColitisColonColon CarcinomaColorectal CancerDNA DamageDevelopmentDiseaseDisease ProgressionDysplasiaEpidemiologic StudiesEpithelialEpithelial CellsEpitheliumGenerationsGenomicsGray unit of radiation doseHomeostasisHyperplasiaImmuneIn SituInflammationInflammatoryInflammatory Bowel DiseasesInjuryIntestinal Intraepithelial NeoplasiaIntestinesKnockout MiceLiverMalignant NeoplasmsMediatingMediator of activation proteinModelingMusMutationMyelogenousMyeloid CellsNeoplasmsNutritionalOxidation-ReductionOxidative StressPatientsPhenotypePlayPolypsPopulationProductionProteinsProtocols documentationRoleSeleniumSelenocysteineSeveritiesSeverity of illnessSodium Dextran SulfateSourceStem cellsSupplementationTestingTissuesTrace ElementsVariantadductcancer preventioncancer riskcarcinogenesiscell behaviorcell injurycell typecytokinecytotoxicitydefined contributionin vivoin vivo Modelinhibitor/antagonistintestinal epitheliumintestinal homeostasismacrophagemouse modeloxidant stressoxidative damagepublic health relevanceresearch studyresponseselenocysteine-tRNAselenoproteinstemnesstumortumorigenesis
项目摘要
DESCRIPTION (provided by applicant): Selenium is a necessary trace element that is incorporated as selenocysteine into selenoproteins, such Selenoprotein P (SEPP1). Several epidemiological studies have inversely correlated nutritional selenium status and cancer risk, particularly in colon cancer. Because SEPP1 is the only selenoprotein to contain more than one selenocysteine, SEPP1 is hypothesized to supply various tissues with selenium to allow in situ generation of selenium containing proteins. However, SEPP1 also contains a redox domain and fulfills a generalized antioxidant function. Such activities suggest that SEPP1 could play a significant role in cancer prevention, and indeed SEPP1 message is downregulated in colorectal cancers. Furthermore, we have found that global SEPP1 reduction increases tumorigenesis in mice placed on a colitis associated carcinoma protocol. But how is SEPP1 mediating these changes in tumor formation? As the majority of SEPP1 is thought to be synthesized in the liver, we previously generated a liver- specific Sepp1 knock-out mouse. Surprisingly, loss of SEPP1 in the liver had no effect on colitis score or tumor formation, suggesting a local source of SEPP1 might modify or influence tumorigenesis. Two possible sources for this locally-derived SEPP1 include 1) intestinal epithelial cells and 2) infiltrating immune cells. Both cell types are known o produce SEPP1, but their separate contributions to inflammatory injury and cancer are yet unknown. Therefore, we will delete SEPP1 in both cell populations individually to define tissue-specific contributions of SEPP1 to inflammatory carcinogenesis. To determine how SEPP1 influences tumor formation, we will utilize a combination of in vivo and ex vivo approaches for both epithelial and myeloid cell populations. Using mouse models of colitis and dysplasia, intestinal enteroid and macrophage/enteroid co-culture, and bone marrow macrophage culture we will determine how tissue-specific SEPP1 affects intestinal homeostasis, intestinal injury, oxidative stress, and macrophage function, and how each function contributes to colitis and associated dysplasia. Interestingly, we have found that Sepp1 loss increases oxidative damage in ex vivo intestinal culture models, and colitis- associated carcinoma is characterized by increased oxidant stress. To specifically investigate the role of oxidative damage and its mechanistic contribution to the SEPP1 phenotype, we will utilize the compound salicylamine, an inhibitor of oxidative adducts, as well as redox-deficient SEPP1 variants. Together, these experiments will elucidate the roles of selenium and SEPP1 in colon disease and disease progression.
描述(由适用提供):硒是一种必要的痕量元素,被掺入硒代半胱氨酸蛋白,例如硒蛋白P(SEPP1)。几项流行病学研究已呈负相关的营养硒状况和癌症风险,尤其是在结肠癌中。由于SEPP1是唯一含有多种硒代半胱氨酸的硒蛋白,因此SEPP1被认为可以用硒提供各种时机,以允许原位含有蛋白质的硒。但是,SEPP1还包含氧化还原域并实现广义抗氧化功能。这些活动表明,SEPP1可以在预防癌症中发挥重要作用,而SEPP1信息实际上在结直肠癌中被下调。此外,我们发现全球SEPP1减少会增加与结肠炎相关癌协议的小鼠的肿瘤发生。但是SEPP1如何介导肿瘤形成的这些变化?由于大多数SEPP1被认为是在肝脏中合成的,因此我们以前产生了肝脏特异性SEPP1敲除小鼠。令人惊讶的是,肝脏中SEPP1的损失对结肠炎评分或肿瘤的形成没有影响,这表明SEPP1的局部来源可能会改变或影响肿瘤发生。该局部衍生的SEPP1的两个可能来源包括1)肠上皮细胞和2)浸润的免疫球。两种细胞类型都是已知的O产生SEPP1,但是它们对炎症损伤和癌症的单独贡献尚不清楚。因此,我们将单独删除两个细胞种群中的SEPP1,以定义SEPP1对炎症性癌变的组织特异性贡献。为了确定SEPP1如何影响肿瘤的形成,我们将利用体内和体内方法的组合用于上皮细胞和髓样细胞群体。使用结肠炎和发育不良的小鼠模型,肠道内肠to和巨噬细胞/胚胎培养以及骨髓巨噬细胞培养,我们将确定组织特异性的SEPP1如何影响肠道稳态,肠道损伤,氧化应激,氧化应激,巨噬细胞和巨噬细胞功能,以及每个功能如何促进肠胃炎和相关的疾病炎。有趣的是,我们发现SEPP1损失会增加体内肠道培养模型中的氧化损伤,而结肠炎相关的癌的特征是氧化物胁迫增加。为了特别研究氧化损伤及其对SEPP1表型的机理贡献,我们将利用复合水杨胺,一种氧化加合物的抑制剂以及氧化还原缺陷的SEPP1变体。总之,这些实验将阐明硒和SEPP1在结肠疾病和疾病进展中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sarah Palmer Short其他文献
Sarah Palmer Short的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sarah Palmer Short', 18)}}的其他基金
Antioxidant regulation of intestinal homeostasis and disease
肠道稳态和疾病的抗氧化调节
- 批准号:
10553707 - 财政年份:2020
- 资助金额:
$ 5.3万 - 项目类别:
Antioxidant regulation of intestinal homeostasis and disease
肠道稳态和疾病的抗氧化调节
- 批准号:
10334557 - 财政年份:2020
- 资助金额:
$ 5.3万 - 项目类别:
p120 and Kaiso dysregulation in intestinal tumorigenesis
p120 和 Kaiso 失调在肠道肿瘤发生中的作用
- 批准号:
8458185 - 财政年份:2012
- 资助金额:
$ 5.3万 - 项目类别:
p120 and Kaiso dysregulation in intestinal tumorigenesis
p120 和 Kaiso 失调在肠道肿瘤发生中的作用
- 批准号:
8256453 - 财政年份:2012
- 资助金额:
$ 5.3万 - 项目类别:
相似国自然基金
抗氧化剂/活性离子时序释放复合支架构建及其修复糖尿病骨缺损的机制研究
- 批准号:32360232
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
塑料抗氧化剂内分泌干扰转化产物的识别与环境行为研究
- 批准号:22306042
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
农用地膜抗氧化剂的土壤污染特征及其微生物效应与机制研究
- 批准号:42377223
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
自然水体轮胎抗氧化剂高毒醌类衍生物非靶向识别及生物转化机制
- 批准号:42377360
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
取代对苯二胺抗氧化剂及其醌衍生物的人体内暴露标志物研究
- 批准号:22306031
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Influence of Particulate Matter on Fetal Mitochondrial Programming
颗粒物对胎儿线粒体编程的影响
- 批准号:
10734403 - 财政年份:2023
- 资助金额:
$ 5.3万 - 项目类别:
Severe neonatal hyperbilirubinemia (SNH) and the expression of UDP-glucuronosyltransferase 1A1 (UGT1A1) play key roles in the development of necrotizing enterocolitis (NEC)
严重新生儿高胆红素血症 (SNH) 和 UDP-葡萄糖醛酸基转移酶 1A1 (UGT1A1) 的表达在坏死性小肠结肠炎 (NEC) 的发生中起关键作用
- 批准号:
10713549 - 财政年份:2023
- 资助金额:
$ 5.3万 - 项目类别:
Defining cell type-specific functions for the selective autophagy receptor p62 in neurons and astrocytes
定义神经元和星形胶质细胞中选择性自噬受体 p62 的细胞类型特异性功能
- 批准号:
10676686 - 财政年份:2023
- 资助金额:
$ 5.3万 - 项目类别:
Identification of Trichomonas vaginalis resistance targets to inform future drug development
确定阴道毛滴虫耐药靶标,为未来药物开发提供信息
- 批准号:
10462312 - 财政年份:2023
- 资助金额:
$ 5.3万 - 项目类别: